The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Sands Frank M. since 2021.
This trader's CIK number is 1870494.
At the time of last reporting, Sands Frank M. was the 10% Owner of Inhibikase Therapeutics, Inc.. (stock ticker symbol IKT).
Also see all insider trading activities at Inhibikase Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | ABOS | 450,000 | $6,696,000 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | IKT | 2,068,965 | $2,999,999 | 0 | $0 | 0 | $0 |
1. Acumen Pharmaceuticals, Inc. (ABOS)
2. Inhibikase Therapeutics, Inc. (IKT)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-07-06 | ABOS | Buy | 450,000 | 14.88 | 6,696,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-11-21 | IKT | Buy | 2,068,965 | 1.45 | 2,999,999 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sands Frank M. (10% Owner of Inhibikase Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.